Stocks Hitting 52-Week Lows

by Lisa Levin, Benzinga Editor

September 16, 2016 10:18 AM | 1 min read |

Novavax, Inc. NVAX shares touched a new 52-week low of $1.27 after reporting disappointing results from two Phase 3 vaccine trials that had previously done well in the Phase 2 trial.
Towerstream Corporation TWER shares fell 17.2 percent to touch a new 52-week low of $1.51. Towerstream priced its 2,962,963 shares offering at $1.35 per share.
Chicago Bridge & Iron Company N.V. CBI shares touched a new 52-week low of $27.58. CB&I declared an interim dividend of $0.07 per share.
Cancer Genetics Inc CGIX shares reached a new 52-week low of $1.78. Cancer Genetics shares have dropped 80.74 percent over the past 52 weeks, while the S&P 500 index has gained 7.62 percent in the same period.

Posted In:

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.